Presentation held by Mats Berencreutz, Executive Vice Presidentat SCA, at the Cheuvreux Pan Europe Forum 22 May 2012.

1. Cheuvreux conference
Mats Berencreutz, Executive Vice President

2. SCA Group in 2011
 Net sales of SEK 106bn
 44,000 employees and sales in more than 100
countries
 World’s third-largest hygiene company
 TEN and Tork are leading global brands for
incontinence care and AFH tissue
 Europe’s second-largest packaging company*
 Europe’s largest private forest owner
 Europe’s second-largest sawmill company
* In January 2012 SCA announced that the Packaging business, excluding the two kraftliner mills, are being divested
2 May 2012

3. Leading market positions
Globally and regionally
Nordic region
North America Incontinence products: 1 Europe
AFH tissue: 3 Baby diapers: 1 Tissue: 1
Incontinence products: 3 AFH tissue: 1 Corrugated board: 2
Consumer tissue: 2 Solid-wood products: 2
Mexico Baby diapers: 3
Incontinence products: 1 Incontinence products: 1
Consumer tissue: 2 Private forest owners: 1
AFH tissue: 3
Asia
Feminine care: 1
Incontinence products: 1
Baby diapers: 3
Globally
Colombia
Incontinence products: 1
Incontinence products: 1
Feminine care: 1 AFH tissue: 2
Tissue: 1
3 May 2012

4. Strong global and regional brands
Two global billion EUR brands
Eastern Europe
Europe
North America
Asia Pacific
Latin America
4 May 2012

5. Major changes
 Acquisition of Georgia-Pacific’s European tissue operations
 Divestment of the Packaging business, excluding
the two kraftliner mills
 Established joint venture in Australia/New Zealand
 Acquisition of Everbeauty an Asian hygiene products company
 Increased shareholding in Vinda
 Acquisition of PISA in Chile
 New hygiene organization
 Acquisition of PLF a French solid-wood products company
5 May 2012

6. Acquisition of Georgia-Pacific’s
European tissue operations
 Creates a leading European tissue
company
 Strengthens SCA’s product offering and
geographic presence
 Sales: EUR 1.25bn
 Purchase price: EUR 1.32bn
 Annual synergies: EUR 125m
 With full implementation of synergies,
earnings per share are expected to
increase by approximately SEK 1.70
6 May 2012

7. Georgia-Pacific acquisition
Substantial synergies
 Increased supply chain efficiency
 Optimization of logistics
 More efficient sourcing
 Improved SG&A and A&P efficiency
 Annual synergies: EUR 125m
 Improves Tissue EBIT margins by
2-2.5 percentage points
 Full effect in 3 years after closing
 Related costs: EUR 130m
7 May 2012

8. Georgia-Pacific acquisition
Enhances SCA’s presence in Consumer and AFH tissue
European Consumer tissue market
25% SCA SCA and GP
35%
European AFH tissue market
SCA and GP
SCA
20% 30%
8 May 2012

9. Georgia-Pacific acquisition
Increased share of branded consumer tissue sales
SCA’s Consumer tissue sales
SCA SCA and GP
Retailers’
Branded brands Branded
Retailers’ 40% 50%
brands
9 May 2012

10. Divestment of Packaging operations
 Divestment of Packaging operations to DS Smith
 Excludes SCA’s two kraftliner mills in Sweden
 Sales: SEK 24.4bn
 Purchase price: EUR 1.7bn on a debt-free basis
 Earnings per share declines by SEK 0.73*
* Based on earnings for the period for 2011
10 May 2012

11. SCA Group
After completion of ongoing transactions
 Net sales of SEK 92bn
 37,000 employees and sales in more than 100
countries
 World’s second-largest hygiene company
 TEN and Tork are leading global brands for
incontinence care and AFH tissue
 Europe’s largest private forest owner
 Europe’s second-largest sawmill company
11 May 2012

12. SCA Group
Hygiene business is growing
% of net sales
~20%*
54% 40%
46% 60% ~80%*
Forest Products and Hygiene products
Packaging (Personal Care and Tissue)
* Provided that the Packaging divestment and the acquisition of Georgia-Pacific’s European tissue business are closed according to plan.
12 May 2012

13. SCA Group’s strategic priorities
EFFICIENCY INNOVATION GROWTH
13 May 2012

14. Efficiency
 Restructuring programme in baby diapers
in Europe completed
 Efficiency programme
 Mainly related to Personal Care and Tissue
 Annual cost saving: SEK 700m
 Gradual impact in 2012-2013
 Investments in upgrade of existing and
new capacity
14 May 2012

15. Innovation
Strengthens market positions and profitability
15 May 2012

16. Growth
 Organic growth of 4%*
 High growth in emerging markets
 Acquisition of Georgia-Pacific´s European tissue
operations
 Acquisition in Brazil
 Pro Descart, No. 2 in incontinence care
 Acquisition in Turkey
 San Saglik 95%, No. 2 in incontinence care
 Komili 50%, No. 4 in baby diapers and feminine care
 Acquisition of Everbeauty an Asian personal care
company
 Continued expansion of wind power opportunities
 Ongoing projects totalling 4 TWh
* Q1 2012 compared with Q1 2011, excluding exchange rate movements and divestments
16 May 2012

17. Acquisition of Everbeauty
Leading Asian personal care company
 Sales: SEK 1.6bn*
 Sales split: baby diapers 60% and incontinence
products 40%
 Purchase price: SEK 1.9bn
 Sales in China, Taiwan and Southeast Asia
 Strong brands, market positions and distribution
• Incontinence care products
• No. 2 in China and No. 1 in Taiwan
• Baby diapers
• No. 5 in China and Taiwan
 Closing expected during summer 2012
* 2010 sales
17 May 2012

18. Growth
Growth potential for hygiene products
 Global population growth
 An aging population
 Increased market penetration
 Higher disposable income
 Customers and consumers demand
more comfort and sustainability
18 May 2012

19. Growth
High potential in markets with low penetration
Usage of hygiene products
Units/capita/year Units/child/year Units/woman/year Kg/capita/year
North America Western Europe Eastern Europe Latin America Asia
19 May 2012

20. Growth
High growth in Emerging markets
Q1 2012
Emerging markets sales growth:
Personal Care: +23%*
Tissue: +14%*
% of Personal Care sales % of Tissue sales
Emerging markets 18% Emerging markets
35%
Mature markets Mature markets
* Adjusted for exchange rate movements
20 May 2012

21. Q&A
21 May 2012

22. IR Contacts:
Johan Karlsson, VP Investor Relations Jessica Ölvestad, Manager Investor Relations
Tel: +46 8 788 51 30 Tel: +46 8 788 52 82
Email: ir@sca.com Website: www.sca.com